← All FR Documents
Notice

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-14786
TypeNotice
PublishedAug 5, 2025
Effective Date-
RIN-
Docket ID-
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (565 words · ~3 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Diabetes and Digestive and Kidney Diseases Advisory Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website ( <E T="03">http://videocast.nih.gov/</E> ). The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> National Diabetes and Digestive and Kidney Diseases Advisory Council. <E T="03">Date:</E> September 17, 2025. <E T="03">Open:</E> 12:30 p.m. to 3:15 p.m. <E T="03">Agenda:</E> Council Business and Concept Clearance. <E T="03">Address:</E> National Institutes of Health, Democracy II, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). <E T="03">Break:</E> 3:15 p.m. to 3:30 p.m. <E T="03">Address:</E> National Institutes of Health, Democracy II, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). <E T="03">Closed:</E> 3:30 p.m. to 4:00 p.m. <E T="03">Agenda:</E> Subcommittee Meetings: Diabetes, Endocrinology, and Metabolic Diseases; Digestive and Nutrition; Kidney, Urologic, and Hematologic Diseases. <E T="03">Address:</E> National Institutes of Health, Democracy II, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). <E T="03">Break:</E> 4:00 p.m. to 4:15 p.m. <E T="03">Address:</E> National Institutes of Health, Democracy II, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). <E T="03">Closed:</E> 4:15 p.m. to 4:30 p.m. <E T="03">Agenda:</E> Full council review and evaluation of Reports for Subcommittees and Consideration of Applications. <E T="03">Address:</E> National Institutes of Health, Democracy II, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). <E T="03">Closed:</E> 4:30 p.m. to 5:00 p.m. <E T="03">Agenda:</E> Executive Closed Session/Annual Intramural Research Program update. <E T="03">Address:</E> National Institutes of Health, Democracy II, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). <E T="03">Contact Person:</E> Karl F. Malik, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 5452, Bethesda, MD 20892, (301) 594-4757, <E T="03">malikk@niddk.nih.gov.</E> Information is also available on the Institute's/Center's home page: <E T="03">https://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/national-diabetes-digestive-kidney-diseases-advisory-council,</E> where an agenda and any additional information for the meeting will be posted when available. <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: July 31, 2025.</DATED> <NAME>Bruce A. George, </NAME> Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-14786 Filed 8-4-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison. View the official version for the authoritative text.